Articles tagged with: development

Jul18

Mathematical modelling and its potential to inform MPT development

Wednesday, 18 July 2018 Tags // cost-effective, development, impact, modelling, product

One of the ongoing challenges in the MPT field is that, because MPT products are not yet commercially available (aside from male and female condoms), we do not have ‘real world’ data to inform product development, introduction, and investment decisions. Given this, MPT product developers, researchers, and funders must grapple with critical questions, such as: How impactful do these products need to be for me to consider funding or starting a product development program? Is that impact potential achievable, and under what conditions? How efficacious would the product need to be? What is the market for the product? How many people would need to use the product correctly and consistently? What associated costs will make a product cost-effective or cost-saving?

May25

Secretariat launches IMPT Advisory Council

Friday, 25 May 2018 Tags // advisory council, development, funder engagement, investment, network, reproductive health, sustainability

We are pleased to announce the launch of the IMPT Advisory Council – a group tasked with providing strategic guidance for the IMPT network, with a particular emphasis on sustainability and new stakeholder engagement.

Jan22

MPT target product profiles

Monday, 22 January 2018 Tags // clinical, development, process, product, regulatory, target-setting, TPP

A critical function of the IMPT Secretariat is to serve as a knowledge manager for the MPT field. In this way, we collect and disseminate MPT-relevant resources, as well as synthesize data and stakeholder expertise into useful tools and frameworks in order to inform future work within the MPT field. While the IMPT Secretariat continues to develop new resources to meet the needs of an evolving field, we want to highlight a tool – originally developed in 2015 – that is still relevant to stakeholders in the MPT field today: generalized Target Product Profiles (TPPs) for intravaginal ring (IVR) MPTs and long-acting injectable MPTs.

Share

Spread the word about the promise of MPTs.

Collaborate

We will go further together – join the movement for MPTs.

Contribute

Your financial and in-kind support can help make MPTs a reality.